Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NT5DC3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
mRNA | GOLPH3L | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | ZCCHC11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
mRNA | NBPF19 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | CLCN4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | ZNF395 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | ZNF157 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | ZBP1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | PLAG1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
mRNA | CWC27 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |